| drug development pathway | The various procedures and studies that must be undertaken to satisfy Food and Drug Administration requirements for drug approval and marketing. (14 Nov 1997) |
|---|---|
| genetic engineering technologies | See: recombinant DNAtechnologies. (09 Oct 1997) |
| recombinant DNA technologies | Procedures used to join together DNA segments in a cell-free system (an environment outside a cell ororganism). Under appropriate conditions, a recombinant DNA molecule canenter a cell and replicate there, either autonomously or after it hasbecome integrated into a cellular chromosome. (09 Oct 1997) |
| growth and embryonic development | Developmental processes from cell division to embryogenesis to postnatal growth and maturity. (12 Dec 1998) |
| state health planning and development agencies | Agencies established under pl93-641 to coordinate, conduct, and implement state health planning activities. Two primary responsibilities are the preparation of an annual state health plan and giving assistance to the statewide health coordinating council. (12 Dec 1998) |
| land conservation and development commission | (LCDC) A commission appointed to determine land use policy in Oregon. (05 Dec 1998) |
| drug-drug interaction | The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity. (09 Oct 1997) |
| drug and narcotic control | Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (drug approval), and marketing of drugs. (12 Dec 1998) |
| united states food and drug administration | An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc. (12 Dec 1998) |
| food and drug administration | The U.S. Agency responsible for regulation of biotechnology foodproducts. The major laws under which the agency has regulatory powersinclude the Food, Drug, and Cosmetic act, and the Public Health Service Act. (09 Oct 1997) |
| Bayley Scales of Infant Development | A psychological test used to measure the developmental progress of infants over the first two and one-half years of life; consists of three scales: mental, motor, and behaviour record. (05 Mar 2000) |
| bone development | Gross development of bones from foetus to adult. It includes osteogenesis, which is restricted to formation and development of bone from the undifferentiated cells of the germ layers of the embryo. It does not include osseointegration. (12 Dec 1998) |
| maxillofacial development | The process of growth and differentiation of the jaws and face. (12 Dec 1998) |
| child development | The continuous sequential physiological and psychological maturing of the child from birth up to but not including adolescence. It includes healthy responses to situations, but does not include growth in stature or size (= growth). (12 Dec 1998) |
| child development disorders, pervasive | Severe distortions in the development of many basic psychological functions that are not normal for any stage in development. These distortions are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements. (12 Dec 1998) |